Northstar Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,343
Closed -$877K 172
2020
Q2
$877K Buy
5,343
+89
+2% +$13.7K 0.37% 74
2020
Q1
$728K Buy
5,254
+260
+5% +$35.7K 0.37% 75
2019
Q4
$656K Sell
4,994
-20
-0.4% -$2.32K 0.27% 95
2019
Q3
$561K Sell
5,014
-98
-2% -$10.9K 0.25% 103
2019
Q2
$566K Buy
5,112
+262
+5% +$30.9K 0.25% 103
2019
Q1
$629K Sell
4,850
-546
-10% -$66.4K 0.29% 94
2018
Q4
$624K Buy
5,396
+1
+0% +$112 0.33% 84
2018
Q3
$579K Sell
5,395
-1,231
-19% -$123K 0.28% 96
2018
Q2
$565K Buy
6,626
+201
+3% +$16.5K 0.28% 103
2018
Q1
$497K Buy
6,425
+907
+16% +$73K 0.25% 108
2017
Q4
$475K Buy
5,518
+331
+6% +$28.2K 0.42% 73
2017
Q3
$451K Sell
5,187
-1,005
-16% -$82.4K 0.44% 75
2017
Q2
$509K Buy
6,192
+200
+3% +$16.3K 0.46% 68
2017
Q1
$513K Buy
+5,992
New +$480K 0.48% 66

Other funds holding LLY

Northstar Wealth Partners's LLY Position: Q3 2020 in Review

Northstar Wealth Partners sold out of Eli Lilly (LLY) in Q3 2020, closing a stake of 5,343 shares — an estimated $877K sold.

Northstar Wealth Partners first reported a position in LLY in Q1 2017 and held it in 14 quarters. The position peaked at $877K in Q2 2020. 1,774 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Northstar Wealth Partners reported no remaining Eli Lilly position as of Q3 2020 after selling out during the quarter.
  • Northstar Wealth Partners sold 5,343 Eli Lilly shares in Q3 2020, an estimated $877K.
  • Northstar Wealth Partners first reported a position in Eli Lilly in Q1 2017 and held it in 14 quarters.
  • Northstar Wealth Partners's Eli Lilly position peaked at $877K in Q2 2020.
  • 1,774 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.